Inventor · disambiguated record
Christopher Szeto
Also filed as: SZETO CHRISTOPHER · SZETO CHRISTOPHER W
12 granted patents·18 pending applications·50 citations·filing 2014–2024
87Inventor score
Top patents by PatentIndex Score
30 records- 0197US11461690B2Distributed machine learning systems, apparatus, and methodsNANT HOLDINGS IP LLC·Filed 2017·Granted Oct 4, 2022·34 cites·35 claims
- 0296US11948687B2Deep learning models for region-of-interest determinationNANTOMICS LLC·Filed 2021·Granted Apr 2, 2024·8 cites·30 claims
- 0395US11694122B2Distributed machine learning systems, apparatus, and methodsNANTOMICS LLC·Filed 2022·Granted Jul 4, 2023·5 cites·20 claims
- 0482US2025062011A1Classification based on characterization analysis methods and systemsNANTOMICS LLC·Filed 2024·Application pending·0 cites
- 0581US2025104869A1Deep Learning Models For Region Of Interest DeterminationNANTOMICS LLC·Filed 2024·Application pending·0 cites
- 0680US12224066B2Deep learning models for region of interest determinationNANTOMICS LLC·Filed 2024·Granted Feb 11, 2025·0 cites·20 claims
- 0779US11195062B2Classification based on characterization analysis methods and systemsNANTOMICS LLC·Filed 2019·Granted Dec 7, 2021·2 cites·21 claims
- 0879US10467523B2Methods and systems for predicting DNA accessibility in the pan-cancer genomeNANTOMICS LLC·Filed 2017·Granted Nov 5, 2019·1 cites·30 claims
- 0979US2025118436A1Deep Learning Models For Tumor EvaluationNANTCELL INC·Filed 2024·Application pending·0 cites
- 1078US12170142B2Classification based on characterization analysis methods and systemsNANTOMICS LLC·Filed 2023·Granted Dec 17, 2024·0 cites·19 claims
- 1173US11676707B2Classification based on characterization analysis methods and systemsNANTOMICS LLC·Filed 2021·Granted Jun 13, 2023·0 cites·21 claims
- 1263US12224064B2Deep learning models for tumor evaluationNANTCELL INC·Filed 2021·Granted Feb 11, 2025·0 cites·16 claims
- 1362US2025270280A1Modified binding proteins and therapeutic uses thereofUNIV MONASH·Filed 2022·Application pending·0 cites
- 1459US11011273B2Pathway analysis for identification of diagnostic testsNANTOMICS LLC·Filed 2014·Granted May 18, 2021·0 cites·12 claims
- 1559US10748056B2Methods and systems for predicting DNA accessibility in the pan-cancer genomeNANTOMICS LLC·Filed 2019·Granted Aug 18, 2020·0 cites·32 claims
- 1659US2016103949A1Paradigm drug response networksFIVE3 GENOMICS LLC·Filed 2014·Application pending·0 cites
- 1752US2021381058A1Evidence based selection of patients for clinical trials using histopathologyNANTOMICS LLC·Filed 2019·Application pending·0 cites
- 1850US2021142864A1Prognostic indicators of poor outcomes in pregnant metastatic breast cancer cohortNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 1950US2022290250A1Genomic-driven targeted therapiesNANTOMICS LLC·Filed 2020·Application pending·0 cites
- 2048US2019292606A1Immune cell signaturesNANTOMICS LLC·Filed 2019·Application pending·0 cites
- 2146US2019295720A1Immune cell signaturesNANTOMICS LLC·Filed 2019·Application pending·0 cites
- 2244US11101038B2Systems and methods for response prediction to chemotherapy in high grade bladder cancerNANTOMICS LLC·Filed 2016·Granted Aug 24, 2021·0 cites·9 claims
- 2344US2020265922A1Comprehensive Genomic Transcriptomic Tumor-Normal Gene Panel Analysis For Enhanced Precision In Patients With CancerNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 2443US2020294622A1Subtyping of TNBC And MethodsNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 2543US2020278353A1Protein Expression Analysis For Breast Cancer Prognosis And TreatmentNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 2642US2019304570A1Mds to aml transition and prediction methods thereforNANTOMICS LLC·Filed 2017·Application pending·0 cites
- 2742US2018039732A1Dasatinib response prediction models and methods thereforNANTOMICS LLC·Filed 2017·Application pending·0 cites
- 2841US2018190381A1Systems And Methods For Patient-Specific Prediction Of Drug Responses From Cell Line GenomicsNANTOMICS LLC·Filed 2016·Application pending·0 cites
- 2938US2018039731A1Ensemble-Based Research Recommendation Systems And MethodsNANTOMICS LLC·Filed 2016·Application pending·0 cites
- 3033US2020190594A1Investigating tumoral and temporal heterogeneity through comprehensive -omics profiling in patients with metastatic triple negative breast cancerNANTOMICS LLC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Szeto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →